|
|
Volumn 401, Issue 6753, 1999, Pages 517-518
|
|
Virus treatment questioned after gene therapy death.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ORNITHINE CARBAMOYLTRANSFERASE;
ADENOVIRUS;
ADULT;
ADVISORY COMMITTEE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CASE REPORT;
FATALITY;
FEVER;
GENE THERAPY;
GENE VECTOR;
GENETICS;
GENETICS AND REPRODUCTION;
GOVERNMENT;
GOVERNMENT REGULATION;
HUMAN;
MALE;
NATIONAL INSTITUTES OF HEALTH;
PHASE 1 CLINICAL TRIAL;
RECOMBINANT DNA ADVISORY COMMITTEE;
RESEARCH SUBJECT;
RISK ASSESSMENT;
THROMBOSIS;
UNIVERSITY OF PENNSYLVANIA;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
NATIONAL INSTITUTES OF HEALTH;
RECOMBINANT DNA ADVISORY COMMITTEE;
UNIVERSITY OF PENNSYLVANIA;
ADENOVIRIDAE;
ADULT;
ADVISORY COMMITTEES;
CLINICAL TRIALS, PHASE I;
FATAL OUTCOME;
FEDERAL GOVERNMENT;
FEVER;
GENE THERAPY;
GENETIC VECTORS;
GOVERNMENT REGULATION;
HUMANS;
MALE;
ORNITHINE CARBAMOYLTRANSFERASE;
RESEARCH SUBJECTS;
RISK ASSESSMENT;
THROMBOSIS;
|
|
EID: 0033533669
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/43977 Document Type: Article |
|
Times cited : (547)
|
|
References (0)
|
